Completed NA INTERVENTIONAL 4-arm NCT04706767

Effect of Co-administration Lidocaine and Dexmedetomidine on Quality of Recovery

Effects of Lidocaine, Dexmedetomidine, and Their Combination on Quality of Recovery Undergoing Laparoscopic Total Hysterectomy

Sponsor: Anqing Municipal Hospital

Conditions Dexmedetomidine Lidocaine Quality of Recovery(QoR-40), Preoperative and Postoperative

Interventions Co-administration Lidocaine and Dexmedetomidine Dexmedetomidine infusion Lidocaine infusion Saline infusion

Updated 5 times since 2021 Last updated: Mar 8, 2022 Started: Jan 28, 2021 Primary completion: Jun 25, 2021 Completion: Jun 25, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Dexmedetomidine and Lidocaine, this trial is completed. The trial is conducted by Anqing Municipal Hospital and has accumulated 5 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Apr 2022 — Jul 2024 [monthly]

Completed NA
Sep 2021 — Apr 2022 [monthly]

Completed NA

Status: Recruiting → Completed
Feb 2021 — Sep 2021 [monthly]

Recruiting NA

First recorded

Jan 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Anqing Municipal Hospital

Data source: Anqing Municipal Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Anqing, China